Digital Pathology Cleared for UK Cancer Screening Programs
New research has led to the U.K. government approving the use of digital pathology to help speed up the analysis of cancer screening samples.
Read MorePosted by Andy Lundin | Jan 25, 2024 | Digital Pathology |
New research has led to the U.K. government approving the use of digital pathology to help speed up the analysis of cancer screening samples.
Read MorePosted by Andy Lundin | Jan 24, 2024 | Cancer |
Researchers developed a new machine-learning tool that could enable earlier cancer detection in patients via smaller blood draws
Read MorePosted by Andy Lundin | Jan 23, 2024 | Lung Cancer |
New noninvasive diagnostic solutions for lung cancer being developed function as a complement to LDCT imaging.
Read MorePosted by Andy Lundin | Jan 16, 2024 | Molecular Diagnostics |
The assay received a final Medicare coverage determination, providing access for Medicare and Medicare Advantage beneficiaries.
Read MorePosted by Andy Lundin | Jan 16, 2024 | Lung Cancer |
The epigenomic technology platform predicts and monitors immunotherapy responses for patients with non-small cell lung cancer (NSCLC).
Read More